Systematic review of antimicrobial treatments for diabetic foot ulcers
- 16 January 2006
- journal article
- review article
- Published by Wiley in Diabetic Medicine
- Vol. 23 (4), 348-359
- https://doi.org/10.1111/j.1464-5491.2006.01785.x
Abstract
Foot ulcers in diabetes are associated with increased mortality, illness and reduced quality of life. Ulcer infection impairs healing and antimicrobial interventions may cure infection, aid healing and reduce amputation rates. To systematically review the evidence for antimicrobial interventions for foot ulcers in diabetes. We searched 16 databases, 11 Internet sites, three books, conference proceedings, a journal and bibliographies in November 2002. We included randomized controlled trials (RCTs) or controlled clinical trials (CCTs). Twenty-three studies investigated the effectiveness or cost-effectiveness of antimicrobial agents: intravenous antibiotics (n = 8); oral antibiotics (n = 5); topical antimicrobials (n = 4); subcutaneous granulocyte-colony stimulating factor (G-CSF) (n = 4); Ayurvedic preparations (n = 1): and sugar vs. antibiotics vs. standard care (n = 1). The trials were small and too dissimilar to be pooled. There is no strong evidence for any particular antimicrobial agent for the prevention of amputation, resolution of infection, or ulcer healing. Pexiganan cream may be as effective as oral ofloxacin for resolution of infection. Ampicillin and sulbactam cost less than imipenem/cilastatin, G-CSF cost less than standard care and cadexomer iodine dressings may cost less than daily dressings. The evidence is too weak to recommend any particular antimicrobial agent. Large studies are needed of the effectiveness and cost-effectiveness of antimicrobial interventions.Keywords
This publication has 38 references indexed in Scilit:
- Randomized Prospective Controlled Trial of Recombinant Granulocyte Colony-Stimulating Factor as Adjunctive Therapy for Limb-Threatening Diabetic Foot InfectionAntimicrobial Agents and Chemotherapy, 2001
- The prevention and treatment of diabetic foot ulcers: a review of clinical effectiveness studiesJournal of Clinical Effectiveness, 1998
- Prospective, Randomized Comparison of Ampicillin/Sulbactam and Cefoxitin for Diabetic Foot InfectionsVascular Surgery, 1997
- Cost-Effectiveness of Ampicillin/Sulbactam Versus Imipenem/Cilastatin in the Treatment of Limb-Threatening Foot Infections in Diabetic PatientsClinical Infectious Diseases, 1997
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- THE EFFECT OF BACTERIAL COLONIZATION ON VENOUS ULCER HEALINGAustralasian Journal of Dermatology, 1992
- Outpatient management of uncomplicated lower-extremity infections in diabetic patientsArchives of Internal Medicine, 1990
- Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or bothAmerican Journal Of Medicine, 1989
- Systemic administration of antibiotics in the management of venous ulcersJournal of the American Academy of Dermatology, 1986
- The Dysvascular Foot: A System for Diagnosis and TreatmentFoot & Ankle, 1981